
    
      The study was designed to compare the rate and extent of absorption of cefprozil from the
      following products under fasting condition:

        1. CEFPROZIL FOR ORAL SUSPENSION USP 250 mg/ 5 mL (Ranbaxy Laboratories Limited, India)

        2. Cefzil TM (CEFPROZIL) for oral suspension equivalent to 250mg/5mL anhydrous, cefprozil
           (Bristol-Myers Squibb Company, New Jersey USA)

        3. Cefzil TM (CEFPROZIL) for oral suspension equivalent to 250mg/5mL anhydrous, cefprozil
           (Bristol-Myers Squibb Company, New Jersey USA)

      The bioequivalence of these formulations was assessed for cefprozil. The study will follow a
      randomized, 3-way cross over, blinded single dose, fasting design in 36 normal healthy,
      nonsmoking male and female subjects
    
  